Fidelity Msci Health Care Index Etf ETF News

Sector ETF report for FHLC

Arkadios Wealth Advisors decreased its stake in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 1.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,180 shares of the companys stock after selling 195 shares during the period. Arkadios Wealth Advisors holdings in []

Prudential Financial Inc. raised its holdings in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 13.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,864 shares of the companys stock after purchasing an additional 470 shares during the []

Demars Financial Group LLC grew its position in Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 10.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 15,255 shares of the companys stock after purchasing an additional 1,484 shares during the period. Demars Financial Group LLCs holdings in Fidelity MSCI Health Care Index ETF were []

Thrivent Financial for Lutherans purchased a new stake in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 3,253 shares of the companys stock, valued at approximately $207,000. Other hedge funds also recently made changes to []

Atlas Brown Inc. boosted its stake in Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 0.6% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,315 shares of the company’s stock after buying an additional 220 shares during the quarter. Atlas Brown Inc.’s holdings […]

Sector ETF report for FHLC

The healthcare sector is expected to witness substantial earnings growth of 17.5% in the third quarter.

Fidelity MSCI Health Care Index is a healthcare sector-focused fund investing in equity.

FHLC: Healthcare Could Outperform SPY

Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that domina

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administratio

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets

Fidelity MSCI Health Care Index ETF: A Lot Going For It